SUPN earnings: real EPS beat/miss history, analyst consensus Buy, P/E -91.79. Updated 2026-07-23.
Supernus Pharmaceuticals (SUPN) Research Hub
Supernus Pharmaceuticals (SUPN) trades on NASDAQ, US in the Healthcare (Drug Manufacturers - Specialty & Generic) sector. As of 2026-09-11, shares last closed at 41.64 USD (-1.02%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -91.79, market cap 2.74B. This hub links to the full technical, earnings and options research available for SUPN.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Drug Manufacturers - Specialty & Generic) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 41.64 USD (-1.02%) |
| 52-week range | 41.5 USD – 51.37 USD |
| Trend regime | Range |
| 14-day RSI | 19.4 (Oversold) |
| Trailing P/E | -91.79 |
| Market cap | 2.74B |
| Dividend yield | 0.00% |
Available research for SUPN
Covered Call on SUPN: how it works, illustrative setup around the real 41.64 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on SUPN: how it works, illustrative setup around the real 41.64 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on SUPN: how it works, illustrative setup around the real 41.64 USD price, max profit/loss, breakeven and when to use it. Educational.
SUPN technical analysis: range, last 41.64 USD, RSI 19.4, 52w range 41.5 USD–51.37 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is SUPN in?
Supernus Pharmaceuticals (SUPN) is classified under Healthcare (Drug Manufacturers - Specialty & Generic), listed on NASDAQ, US.
Is SUPN in an uptrend or downtrend?
As of 2026-09-11, SUPN is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is SUPN's trailing P/E ratio?
SUPN's trailing P/E is -91.79, with a market cap of 2.74B. See the earnings research page for full valuation detail.